American pharmaceutical company Eli Lilly announced last week that it had seen encouraging clinical trial results of its new Alzheimer's medication. According to the company, their experimental drug, donanemab, was shown ...
May 10, 2023
0
11
For the first time, researchers described the structure of a special type of amyloid beta plaque protein associated with Alzheimer's disease (AD) progression. In a report published May 10 in the journal Neuron, scientists ...
May 10, 2023
0
91
New research finds that the brains of otherwise healthy military personnel who are exposed to explosions show an abnormal brain accumulation of amyloid-beta protein—a protein that plays a role in the development of Alzheimer's ...
May 9, 2023
0
8
A deep slumber might help buffer against memory loss for older adults facing a heightened burden of Alzheimer's disease, new research from the University of California, Berkeley, suggests.
May 4, 2023
0
273
US pharmaceutical giant Eli Lilly on Wednesday announced its experimental Alzheimer's drug significantly slowed cognitive and functional decline, results hailed as "remarkable" by experts despite some patients experiencing ...
May 3, 2023
0
129
The exercise was simple: inhale for a count of five, then exhale for a count of five. Do that for 20 minutes, twice a day, for four weeks.
May 1, 2023
1
604
A recent study revealed that a protein important for neuron communication is associated with patient resistance to Alzheimer's disease and may delay cognitive decline.
Apr 27, 2023
0
8
Changes in blood vessels in the brain linked to the build-up of a sticky protein known as amyloid beta are a hallmark of early-stage Alzheimer's disease. As amyloid accumulates on the walls of vessels, brain cells lose nutrients ...
Apr 26, 2023
0
41
Scientists have been working to understand the root causes of dementia and Alzheimer's disease for decades now. But one of the reasons we don't yet have a cure for this disease is because of the complexity of the human brain—alongside ...
Mar 21, 2023
0
14
A newly discovered "energy switch" in the immune cells of the brain may lead to the development of drugs for Alzheimer's disease, the most common form of dementia.
Mar 15, 2023
0
82
